These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 2946502)
1. Immunohistochemical analysis of C3 cleavage fragments, factor H, and the C5b-9 terminal complex of complement in de novo membranous glomerulonephritis occurring in patients with renal transplant. Cosyns JP; Kazatchkine MD; Bhakdi S; Mandet C; Grossetete J; Hinglais N; Bariety J Clin Nephrol; 1986 Oct; 26(4):203-8. PubMed ID: 2946502 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study of the C5b-9 complex of complement in human kidneys. Hinglais N; Kazatchkine MD; Bhakdi S; Appay MD; Mandet C; Grossetete J; Bariety J Kidney Int; 1986 Sep; 30(3):399-410. PubMed ID: 3537447 [TBL] [Abstract][Full Text] [Related]
3. Complement in ANCA-associated glomerulonephritis. Hilhorst M; van Paassen P; van Rie H; Bijnens N; Heerings-Rewinkel P; van Breda Vriesman P; Cohen Tervaert JW; Nephrol Dial Transplant; 2017 Aug; 32(8):1302-1313. PubMed ID: 26275893 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathological study of de novo membranous nephropathy of 'stage 0' after kidney transplantation. Katsuma A; Nakada Y; Yamamoto I; Horita S; Katsumata H; Kobayashi A; Unagami K; Okumi M; Ishida H; Yokoo T; Yamaguchi Y; Tanabe K; Nephrology (Carlton); 2018 Jul; 23 Suppl 2():63-69. PubMed ID: 29968407 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical study of complement S protein (Vitronectin) in normal and diseased human kidneys: relationship to neoantigens of the C5b-9 terminal complex. Bariety J; Hinglais N; Bhakdi S; Mandet C; Rouchon M; Kazatchkine MD Clin Exp Immunol; 1989 Jan; 75(1):76-81. PubMed ID: 2467771 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of the terminal C5b-9 complement complex in children with glomerular diseases. Rus HG; Niculescu F; Nanulescu M; Cristea A; Florescu P Clin Exp Immunol; 1986 Jul; 65(1):66-72. PubMed ID: 3539428 [TBL] [Abstract][Full Text] [Related]
7. Alternative C3 pathway activiation in pneumococcal glomerulonephritis. Hyman LR; Jenis EH; Hill GS; Zimmerman SW; Burkholder PM Am J Med; 1975 Jun; 58(6):810-4. PubMed ID: 1094828 [TBL] [Abstract][Full Text] [Related]
8. Demonstration of C3d deposits in membranous nephropathy. Doi T; Kanatsu K; Nagai H; Suehiro F; Kuwahara T; Hamashima Y Nephron; 1984; 37(4):232-5. PubMed ID: 6379483 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical localization of C3d fragment of complement and S-protein (vitronectin) in normal and diseased human kidneys: association with the C5b-9 complex and vitronectin receptor. Okada M; Yoshioka K; Takemura T; Akano N; Aya N; Murakami K; Maki S Virchows Arch A Pathol Anat Histopathol; 1993; 422(5):367-73. PubMed ID: 8322453 [TBL] [Abstract][Full Text] [Related]
11. Immunopathology of the end-stage kidney. Immunoglobulin and complement component deposition in nonimmune disease. Velosa J; Miller K; Michael AF Am J Pathol; 1976 Jul; 84(1):149-62. PubMed ID: 779494 [TBL] [Abstract][Full Text] [Related]
12. Localization of the membrane attack complex (MAC) in experimental immune complex glomerulonephritis. Koffler D; Biesecker G; Noble B; Andres GA; Martinez-Hernandez A J Exp Med; 1983 Jun; 157(6):1885-905. PubMed ID: 6343549 [TBL] [Abstract][Full Text] [Related]
13. Membranoproliferative glomerulonephritis. Localization of early components of complement in glomerular deposits. Davis BK; Cavallo T Am J Pathol; 1976 Aug; 84(2):283-98. PubMed ID: 133617 [TBL] [Abstract][Full Text] [Related]
14. Complement activation is associated with crescent formation in IgA nephropathy. Itami H; Hara S; Samejima K; Tsushima H; Morimoto K; Okamoto K; Kosugi T; Kawano T; Fujiki K; Kitada H; Hatakeyama K; Tsuruya K; Ohbayashi C Virchows Arch; 2020 Oct; 477(4):565-572. PubMed ID: 32300880 [TBL] [Abstract][Full Text] [Related]
15. Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis. Schulze M; Pruchno CJ; Burns M; Baker PJ; Johnson RJ; Couser WG Am J Pathol; 1993 Jan; 142(1):179-87. PubMed ID: 7678717 [TBL] [Abstract][Full Text] [Related]
16. C5b-9 deposition in children with glomerular diseases. Nanulescu M; Rus HG; Niculescu F; Cristea A; Florescu P Med Interne; 1987; 25(2):99-104. PubMed ID: 3303285 [TBL] [Abstract][Full Text] [Related]
17. Immunofluorescence studies of dense deposit disease. The presence of railroad tracks and mesangial rings. Kim Y; Vernier RL; Fish AJ; Michael AF Lab Invest; 1979 Apr; 40(4):474-80. PubMed ID: 372673 [TBL] [Abstract][Full Text] [Related]
18. Cutaneous vascular deposition of C5b-9 and its role as a diagnostic adjunct in the setting of diabetes mellitus and porphyria cutanea tarda. Vasil KE; Magro CM J Am Acad Dermatol; 2007 Jan; 56(1):96-104. PubMed ID: 17190626 [TBL] [Abstract][Full Text] [Related]
19. Activated C3 (C3b) in the nephritic glomerulus. Pan C; Strife CF; McAdams AJ; West CD Pediatr Nephrol; 1993 Aug; 7(4):379-86. PubMed ID: 8398646 [TBL] [Abstract][Full Text] [Related]
20. Demonstration of apoptosis-associated cleavage products of DNA, complement activation products SC5b-9 and C3d/dg, and immune complexes CIC-C3d, CIC-IgA, and CIC-IgG in the urine of patients with membranous glomerulonephritis. Kotnik V; Premzl A; Skoberne M; Malovrh T; Kveder R; Kaplan-Pavlovcic S; Kotnik A; Stiblar-Martincic D Croat Med J; 2003 Dec; 44(6):707-11. PubMed ID: 14652883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]